358 related articles for article (PubMed ID: 19673621)
1. Prucalopride: a new drug for the treatment of chronic constipation.
Tack J
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
Quigley EM; Vandeplassche L; Kerstens R; Ausma J
Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
[TBL] [Abstract][Full Text] [Related]
3. Tegaserod for constipation-predominant irritable bowel syndrome.
Kale-Pradhan PB; Wilhelm SM
Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
[TBL] [Abstract][Full Text] [Related]
4. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
Kamm MA
Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
[TBL] [Abstract][Full Text] [Related]
7. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy options for patients with irritable bowel syndrome.
Talley NJ
Am J Manag Care; 2001 Jul; 7(8 Suppl):S261-7. PubMed ID: 11474911
[TBL] [Abstract][Full Text] [Related]
9. Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study.
Fujita T; Yokota S; Sawada M; Majima M; Ohtani Y; Kumagai Y
J Clin Pharm Ther; 2005 Dec; 30(6):611-22. PubMed ID: 16336295
[TBL] [Abstract][Full Text] [Related]
10. Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride.
Boeckxstaens GE; Bartelsman JF; Lauwers L; Tytgat GN
Am J Gastroenterol; 2002 Jan; 97(1):194-7. PubMed ID: 11811166
[TBL] [Abstract][Full Text] [Related]
11. Review article: tegaserod for chronic constipation.
Johanson JF
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():20-4. PubMed ID: 15521851
[TBL] [Abstract][Full Text] [Related]
12. Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.
Sullivan KL; Staffetti JF; Hauser RA; Dunne PB; Zesiewicz TA
Mov Disord; 2006 Jan; 21(1):115-6. PubMed ID: 16142776
[TBL] [Abstract][Full Text] [Related]
13. 5-HT4 receptor agonists: similar but not the same.
De Maeyer JH; Lefebvre RA; Schuurkes JA
Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
[TBL] [Abstract][Full Text] [Related]
14. Motility: prucalopride for chronic constipation.
Bassotti G; Villanacci V
Nat Rev Gastroenterol Hepatol; 2009 Jun; 6(6):324-5. PubMed ID: 19494821
[No Abstract] [Full Text] [Related]
15. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.
Di Palma JA; Cleveland MV; McGowan J; Herrera JL
Am J Gastroenterol; 2007 Sep; 102(9):1964-71. PubMed ID: 17573794
[TBL] [Abstract][Full Text] [Related]
16. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
Coremans G; Kerstens R; De Pauw M; Stevens M
Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
[TBL] [Abstract][Full Text] [Related]
17. [Tegaserod in treatment of women with irritable bowel syndrome].
Munck LK; Ainsworth MA
Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled trial of prucalopride for severe chronic constipation.
Camilleri M; Kerstens R; Rykx A; Vandeplassche L
N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
[TBL] [Abstract][Full Text] [Related]
19. Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study.
Vigone B; Caronni M; Severino A; Bellocchi C; Baldassarri AR; Fraquelli M; Montanelli G; Santaniello A; Beretta L
Arthritis Res Ther; 2017 Jun; 19(1):145. PubMed ID: 28633671
[TBL] [Abstract][Full Text] [Related]
20. Tegaserod for treating chronic constipation in elderly patients.
Baun RF; Levy HB
Ann Pharmacother; 2007 Feb; 41(2):309-13. PubMed ID: 17227825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
